Kintara Therapeutics Inc (KTRA) 14-day ATR is 0.02: This Stock is Set to Soar Above its Peers

Kintara Therapeutics Inc (NASDAQ: KTRA) started the day on Wednesday, with a price increase of 63.35% at $0.16, before settling in for the price of $0.10 at the close. Taking a more long-term approach, KTRA posted a 52-week range of $0.08-$5.98.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 0.00%. Meanwhile, its Annual Earning per share during the time was 49.09%. This publicly-traded company’s shares outstanding now amounts to $39.04 million, simultaneously with a float of $38.96 million. The organization now has a market capitalization sitting at $6.40 million. At the time of writing, stock’s 50-day Moving Average stood at $0.1068, while the 200-day Moving Average is $2.0010.

Kintara Therapeutics Inc (KTRA) Ownership Facts and Figures

Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Kintara Therapeutics Inc’s current insider ownership accounts for 0.19%, in contrast to 0.62% institutional ownership.

Kintara Therapeutics Inc (KTRA) Earnings and Revenue Records

In the latest quarterly report released, which was put into the public domain on 6/29/2023, the organization reported -$1.95 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -$1.05) by -$0.9. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.

Kintara Therapeutics Inc (NASDAQ: KTRA) Trading Performance Indicators

Let’s observe the current performance indicators for Kintara Therapeutics Inc (KTRA). It’s Quick Ratio in the last reported quarter now stands at 0.63. The Stock has managed to achieve an average true range (ATR) of 0.02.

In the same vein, KTRA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -5.98.

Technical Analysis of Kintara Therapeutics Inc (KTRA)

If we take a close look at the recent performances of Kintara Therapeutics Inc (NASDAQ: KTRA), its last 5-days Average volume was 54.1 million that shows progress from its year to date volume of 14.97 million. During the previous 9 days, stock’s Stochastic %D was recorded 57.25% While, its Average True Range was 0.0242.

Raw Stochastic average of Kintara Therapeutics Inc (KTRA) in the period of the previous 100 days is set at 13.90%, which indicates a major fall in contrast to 50.65% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 234.52% that was higher than 148.35% volatility it exhibited in the past 100-days period.